| scholarly article | Q13442814 |
| P50 | author | Denisa Wagner | Q30143521 |
| P2093 | author name string | Ayce Yesilaltay | |
| Monty Krieger | |||
| Wolfgang Bergmeier | |||
| Eliza Vasile | |||
| Michael Bernimoulin | |||
| Vandana S Dole | |||
| Jana Matuskova | |||
| P2860 | cites work | Assessment of the sites of red cell destruction using quantitative measurements of splenic and hepatic red cell destruction | Q70305082 |
| Surface morphology of platelets in spur-cell anemia | Q70371496 | ||
| Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion | Q71022902 | ||
| Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis | Q71354028 | ||
| Red cell lipid abnormalities in acquired acanthocytosis are extended to platelets | Q72891112 | ||
| P-Selectin and platelet clearance | Q77620636 | ||
| Platelet P-selectin facilitates atherosclerotic lesion development | Q78654773 | ||
| PDZK1 is required for maintaining hepatic scavenger receptor, class B, type I (SR-BI) steady state levels but not its surface localization or function | Q79988027 | ||
| Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I/apolipoprotein E double knockout mice | Q81363077 | ||
| Kinetics of In-111-platelets in the baboon: II. In vitro distribution and sites of sequestration | Q93624678 | ||
| Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease) | Q24294344 | ||
| A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism | Q24646308 | ||
| Targeted Disruption of the PDZK1 Gene in Mice Causes Tissue-specific Depletion of the High Density Lipoprotein Receptor Scavenger Receptor Class B Type I and Altered Lipoprotein Metabolism | Q28208721 | ||
| Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
| Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice | Q28365792 | ||
| Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
| Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
| Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. | Q30310323 | ||
| Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets | Q33349386 | ||
| Stomatocytic haemolysis and macrothrombocytopenia (Mediterranean stomatocytosis/macrothrombocytopenia) is the haematological presentation of phytosterolaemia | Q33367390 | ||
| Programmed anuclear cell death delimits platelet life span. | Q33374664 | ||
| Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia. | Q33378034 | ||
| Immunology and Clinical Importance of Antiphospholipid Antibodies | Q33379907 | ||
| The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. | Q33890246 | ||
| Platelet hypersensitivity induced by cholesterol incorporation | Q34475652 | ||
| New insights into erythropoiesis | Q34530985 | ||
| The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues | Q35146324 | ||
| Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse | Q35163535 | ||
| Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology | Q35603368 | ||
| Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. | Q36406570 | ||
| Cholesterol sensing, trafficking, and esterification. | Q36497100 | ||
| Free cholesterol in atherosclerotic plaques: where does it come from? | Q36947976 | ||
| Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia | Q40041027 | ||
| Cyclic AMP metabolism in cholesterol-rich platelets | Q40073141 | ||
| Thrombopoietin, the c-mpl ligand, is a major regulator of platelet production | Q40531032 | ||
| Glycosylation restores survival of chilled blood platelets | Q40635116 | ||
| The effect of atorvastatin on platelet function in patients with coronary artery disease | Q42464672 | ||
| Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells | Q42816094 | ||
| Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. | Q43893087 | ||
| Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice | Q45020519 | ||
| Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo | Q45042577 | ||
| HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes | Q46786279 | ||
| Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility | Q46892860 | ||
| Lipid composition of subcellular particles of human blood platelets. | Q49085698 | ||
| Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation. | Q50948591 | ||
| Effects of dietary and pharmacologic alteration of serum lipids on platelet survival time | Q67352454 | ||
| Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency | Q67810020 | ||
| Erythrocyte membrane alterations and plasma lipids in patients with chylomicronemia and in Tangier disease | Q70147709 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 1111-1116 | |
| P577 | publication date | 2008-04-24 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice | |
| P478 | volume | 28 |
| Q37211062 | "Who's on first": determining the roster for the key players in the reverse cholesterol transport pathway |
| Q34017080 | APOε4 is associated with enhanced in vivo innate immune responses in human subjects |
| Q53214960 | ATP-binding cassette transporter 1 (ABCA1) deficiency decreases platelet reactivity and reduces thromboxane A2 production independently of hematopoietic ABCA1. |
| Q40157600 | Association of lipid profile alterations with severe forms of dengue in humans |
| Q33435708 | Carboxy-terminal deletion of the HDL receptor reduces receptor levels in liver and steroidogenic tissues, induces hypercholesterolemia, and causes fatal heart disease |
| Q34921017 | Challenges in using cultured primary rodent hepatocytes or cell lines to study hepatic HDL receptor SR-BI regulation by its cytoplasmic adaptor PDZK1 |
| Q36825794 | Cholesterol in platelet biogenesis and activation |
| Q34948139 | Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis |
| Q34581244 | Excess cholesterol induces mouse egg activation and may cause female infertility. |
| Q30528268 | Extrahepatic high-density lipoprotein receptor SR-BI and apoA-I protect against deep vein thrombosis in mice. |
| Q37667665 | Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks |
| Q37226719 | HDL endocytosis and resecretion |
| Q38391229 | HDL particle subpopulations: Focus on biological function |
| Q28513943 | Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice |
| Q34565254 | High density lipoprotein: it's not just about lipid transport anymore |
| Q38217201 | High-density lipoprotein as a modulator of platelet and coagulation responses |
| Q27664175 | In Vitro and in Vivo Analysis of the Binding of the C Terminus of the HDL Receptor Scavenger Receptor Class B, Type I (SR-BI), to the PDZ1 Domain of Its Adaptor Protein PDZK1 |
| Q35776623 | Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice |
| Q38293457 | Mouse models of disturbed HDL metabolism |
| Q34726050 | Negatively cooperative binding of high-density lipoprotein to the HDL receptor SR-BI |
| Q91942498 | Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo |
| Q37226752 | Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia |
| Q33801221 | Platelet hyperreactivity, scavenger receptors and atherothrombosis |
| Q37162996 | Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond |
| Q29147547 | Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease |
| Q34397435 | Regulation of platelet function by class B scavenger receptors in hyperlipidemia |
| Q37222723 | Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population |
| Q57123755 | Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins |
| Q37814204 | Review of the putative cell-surface receptors for alpha-fetoprotein: identification of a candidate receptor protein family |
| Q46267459 | Role of apolipoproteins, ABCA1 and LCAT in the biogenesis of normal and aberrant high density lipoproteins. |
| Q47377607 | Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering |
| Q57786797 | SR-BI (Scavenger Receptor Class B Type 1) Is Critical in Maintaining Normal T-Cell Development and Enhancing Thymic Regeneration |
| Q35215415 | Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia |
| Q33393289 | Scavenger receptor BI: a multi-purpose player in cholesterol and steroid metabolism |
| Q24299462 | Scavenger receptor SR-BI in macrophage lipid metabolism |
| Q37851971 | Scavenger receptor class B, type I: a promising immunotherapy target. |
Search more.